The effect of bone marrow-derived mesenchymal stem cells to induce PD-L1 molecule on splenic lymphocytes
Background: Mesenchymal stem cells are non-hematopoietic stromal cells that are used in the treatment of many chronic and autoimmune diseases by modulating the immune system. Due to the limitations of using autologous mesenchymal stem cells, the use of allogeneic stem cells is a promising therapeuti...
Main Authors: | Bahare Hasani Karmozdi, Alireza Mardomi, Saeid Abediankenari |
---|---|
Format: | Article |
Language: | fas |
Published: |
Tehran University of Medical Sciences
2021-11-01
|
Series: | Tehran University Medical Journal |
Subjects: | |
Online Access: | http://tumj.tums.ac.ir/article-1-11388-en.html |
Similar Items
-
Immunoregulatory Properties of Human Bone Marrow Mesenchymal Stem Cells on T Lymphocyte Proliferation
by: Masoumeh Masoumi Karimi, et al.
Published: (2012-02-01) -
Over-Expression of Immunosuppressive Molecules, PD-L1 and PD-L2, in Ulcerative Colitis Patients
by: Zeinab Rajabian, et al.
Published: (2019-03-01) -
Introducing a New SYBR green Real-time PCR for Detection of SARS-CoV2 Virus Genome
by: Alireza Mardomi, et al.
Published: (2022-03-01) -
Feasibility of bone marrow mesenchymal stem cells harvesting from forearm bone
by: Tulyapruek Tawonsawatruk, et al.
Published: (2021-07-01) -
Human bone marrow-derived mesenchymal stem cells
by: Lopez M, et al.
Published: (2007-01-01)